Conditions: Multiple Sclerosis
Keywords: Multiple Sclerosis MS Fingolimod Gilenya ECG Bradyarrythmia conduction abnormalities first dose observation
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 6998
Healthy volunteers: no

Brief summary:
This study evaluated bradycardiac events during first dose observation of fingolimod in MS patients.

Detailed description:

Arms:
arm 1: Fingolimod 0.5 mg by mouth once daily for 7 days.

Interventions: intervention 1: FTY720
Intervention descriptions: intervention 1: None

Protocol document: